Fluorinated isoquinoline [a] pyrrole compounds and preparation method thereof
A technology for fluoroisoquinoline and compounds, applied in the field of fluoroisoquinoline[a]pyrrole compounds and their preparation, capable of solving harsh conditions, cumbersome routes, and few methods for isoquinoline[a]pyrrole compounds, etc. problem, achieve the effect of low cost and good substrate compatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Example 1: preparation of
[0032] 3.4mg (0.02mmol) of AgNO 3 , 5.0mg (0.02mmol) of oxazoline ligand Ligand I, 22.2mg (0.3mmol) of Li 2 CO 3 , 157.5mg (0.5mmol) of N-fluorobisbenzenesulfonamide (NFSI) was added to the reaction tube, 1.5mL of N,N-dimethylacetamide was added, and then 25.7mg (0.1mmol) of alkyne substrate was added Add 21.3mg (0.15mmol) of methyl butynedicarboxylate, stir and react at 60°C for 5 hours; add water, extract with ether, combine the extracts, concentrate, perform column chromatography, and elute with ethyl acetate and petroleum ether gradient, 24.9 mg of product were obtained The yield is 60%.
[0033] 1 H NMR (400MHz, CDCl 3 ):8.48-8.39(m,1H),7.89-7.82(m,1H),7.61-7.51(m,2H),4.01(s,3H),3.98(s,3H),3.91(s,3H), 3.07(td, J=7.2,3.6Hz,2H),1.56(tt,J=7.2,7.2Hz,2H),1.34(tq,J=7.2,7.2Hz,2H),0.92(t,J=7.2Hz ,3H);
[0034] 13 C NMR (100MHz, CDCl 3 ): 166.5, 163.9, 162.7, 148.4(d, J=236.1Hz), 128.9, 128.7, 128.3, 124.0(d, J=3.1Hz), 123.9(d, J=3...
Embodiment 2
[0037] Example 2: preparation of
[0038] 3.4mg (0.02mmol) of AgNO 3 , 5.0mg (0.02mmol) of oxazoline ligand Ligand I, 22.2mg (0.3mmol) of Li 2 CO 3 , 157.5mg (0.5mmol) of N-fluorobisbenzenesulfonamide (NFSI) was added to the reaction tube, 1.5mL of N,N-dimethylacetamide was added, and then 28.1mg (0.1mmol) of alkyne substrate was added Add 21.3mg (0.15mmol) of methyl butynedicarboxylate, stir and react at 60°C for 5 hours; add water, extract with ether, combine the extracts, concentrate, perform column chromatography, and elute with ethyl acetate and petroleum ether gradient, 36.4 mg of product were obtained The yield was 83%.
[0039] 1 H NMR (400MHz, CDCl 3):8.48(dd, J=6.0,2.4Hz,1H),8.87(dd,J=6.0,2.8Hz,1H),7.61-7.53(m,2H),6.03-5.96(m,1H),4.00( s,3H),3.91(s,3H),3.88(s,3H),2.48-2.37(m,2H),2.26-2.07(m,2H),1.87-1.77(m,2H),1.76-1.64( m,2H);
[0040] 13 C NMR (100MHz, CDCl 3 ):.166.4,163.8,162.0,147.0(d,J=237.4Hz),133.3(d,J=1.1Hz),128.8,128.4,128.3(d,J=1.1Hz),128.1,...
Embodiment 3
[0043] Example 3: preparation of
[0044] 3.4mg (0.02mmol) of AgNO 3 , 5.0mg (0.02mmol) of oxazoline ligand Ligand I, 22.2mg (0.3mmol) of Li 2 CO 3 , 157.5mg (0.5mmol) of N-fluorobisbenzenesulfonamide (NFSI) was added to the reaction tube, 1.5mL of N,N-dimethylacetamide was added, and then 28.3mg (0.1mmol) of alkyne substrate was added Add 21.3mg (0.15mmol) of methyl butynedicarboxylate, stir and react at 60°C for 5 hours; add water, extract with ether, combine the extracts, concentrate, perform column chromatography, and elute with ethyl acetate and petroleum ether gradient, 27.8 mg of product were obtained The yield was 63%.
[0045] 1 H NMR (400MHz, CDCl 3 ):7.69-7.61(m,1H),7.56-7.38(m,6H),3.97-3.91(m,6H),3.24(s,3H);
[0046] 13 C NMR (100MHz, CDCl 3 ):.165.6,163.3,159.5,147.3(d,J=241.5Hz),132.8,131.3,130.4,129.9(d,J=18.2Hz),129.8,129.2,128.9,128.5,127.8(d,J=2.0 Hz), 122.6(d, J=29.8Hz), 119.2, 118.6, 102.7, 52.7, 51.7, 51.6;
[0047] 19 F NMR (376MHz, CDCl ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com